Literature DB >> 12470249

Trends in virtual combinatorial library design.

Gisbert Schneider1.   

Abstract

Recent developments in combinatorial molecular design using virtual screening methods are summarised. These include similarity-based compound clustering techniques, structure-based docking and scoring, and fragment-based de novo design. Three major trends have been identified: i) the design of small target-focused compound libraries yielding activity-enriched sets of molecules; ii) advanced prediction methods for "drug-like" molecular properties complement activity predictions in the library design process, forming a multi-dimensional objective function; iii) "cherry picking" of selected products is increasingly used in lead generation and optimisation compared to purely educt-driven library design methods aiming at maximising structural diversity.

Mesh:

Year:  2002        PMID: 12470249     DOI: 10.2174/0929867023368755

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  19 in total

Review 1.  Comparative molecular surface analysis: a novel tool for drug design and molecular diversity studies.

Authors:  Jaroslaw Polanski; Rafal Gieleciak
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

2.  Comparison of correlation vector methods for ligand-based similarity searching.

Authors:  Uli Fechner; Lutz Franke; Steffen Renner; Petra Schneider; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2003-10       Impact factor: 3.686

3.  Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps.

Authors:  Zhi Wang; Aixia Yan
Journal:  Mol Divers       Date:  2010-11-12       Impact factor: 2.943

4.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

5.  The multiple roles of computational chemistry in fragment-based drug design.

Authors:  Richard Law; Oliver Barker; John J Barker; Thomas Hesterkamp; Robert Godemann; Ole Andersen; Tara Fryatt; Steve Courtney; Dave Hallett; Mark Whittaker
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

6.  Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists.

Authors:  Bjoern A Krueger; Tanja Weil; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

7.  How "drug-like" are naturally occurring anti-cancer compounds?

Authors:  Fidele Ntie-Kang; Lydia L Lifongo; Philip N Judson; Wolfgang Sippl; Simon M N Efange
Journal:  J Mol Model       Date:  2014-01-24       Impact factor: 1.810

8.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03

9.  Seaweed metabolite database (SWMD): A database of natural compounds from marine algae.

Authors:  G Dicky John Davis; A Hannah Rachel Vasanthi
Journal:  Bioinformation       Date:  2011-01-22

10.  Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach.

Authors:  Fidele Ntie-Kang; James A Mbah; Lydia L Lifongo; Luc C Owono Owono; Eugene Megnassan; Luc Meva'a Mbaze; Philip N Judson; Wolfgang Sippl; Simon Mn Efange
Journal:  Org Med Chem Lett       Date:  2013-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.